Diagnosis and treatment of non-Hodgkin's lymphoma of adults

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The non-Hodgkin's lymphomas (NHL) represent a diverse group of neoplasms with many different clinical presentations, associated laboratory abnormalities, responsiveness to treatment, and clinical outcome. The cell of origin and stage of maturation arrest prior to uncontrolled proliferation are important to the understanding of this diversity (Table 47.1). In the USA, the incidence of NHL steadily increases from childhood through age 80 years; unlike Hodgkin's disease, no peak incidence exists for young adults. NHL is the fifth most common malignancy in men and women, respectively, and is among the most rapidly increasing malignancies [1]. They represent the seventh most common cause of death from cancer in the USA, with the age-adjusted incidence being about three times that of Hodgkin's disease [1]. The incidence of non-Hodgkin's lymphoma is twice as frequent among whites as blacks, and there is an almost 50 % increase in presentation in males compared with females. The reason for this gender and race predominance is unknown; however, it may reflect a different pattern of occupational exposure or a difference in the immune status of males compared with females. Links among agricultural work (organochlorine-based pesticides), wood products, and organic solvents have been established [2].

Original languageEnglish (US)
Title of host publicationNeoplastic Diseases of the Blood
PublisherSpringer New York
Pages1027-1047
Number of pages21
ISBN (Electronic)9781461437642
ISBN (Print)1461437636, 9781461437635
DOIs
StatePublished - Nov 1 2013

Fingerprint

Non-Hodgkin's Lymphoma
Incidence
Hodgkin Disease
Neoplasms
Occupational Exposure
Therapeutics
Pesticides
Young Adult
Cause of Death

Keywords

  • Bone marrow biopsy
  • Chemotherapy
  • Combination chemotherapy
  • Lymph node biopsy
  • Monoclonal antibody therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Diagnosis and treatment of non-Hodgkin's lymphoma of adults. / Faber, Edward A.; Vose, Julie Marie; Armitage, James Olen; Bierman, Philip Jay.

Neoplastic Diseases of the Blood. Springer New York, 2013. p. 1027-1047.

Research output: Chapter in Book/Report/Conference proceedingChapter

Faber, Edward A. ; Vose, Julie Marie ; Armitage, James Olen ; Bierman, Philip Jay. / Diagnosis and treatment of non-Hodgkin's lymphoma of adults. Neoplastic Diseases of the Blood. Springer New York, 2013. pp. 1027-1047
@inbook{eb02be25956e46da962cac18274e4e0b,
title = "Diagnosis and treatment of non-Hodgkin's lymphoma of adults",
abstract = "The non-Hodgkin's lymphomas (NHL) represent a diverse group of neoplasms with many different clinical presentations, associated laboratory abnormalities, responsiveness to treatment, and clinical outcome. The cell of origin and stage of maturation arrest prior to uncontrolled proliferation are important to the understanding of this diversity (Table 47.1). In the USA, the incidence of NHL steadily increases from childhood through age 80 years; unlike Hodgkin's disease, no peak incidence exists for young adults. NHL is the fifth most common malignancy in men and women, respectively, and is among the most rapidly increasing malignancies [1]. They represent the seventh most common cause of death from cancer in the USA, with the age-adjusted incidence being about three times that of Hodgkin's disease [1]. The incidence of non-Hodgkin's lymphoma is twice as frequent among whites as blacks, and there is an almost 50 {\%} increase in presentation in males compared with females. The reason for this gender and race predominance is unknown; however, it may reflect a different pattern of occupational exposure or a difference in the immune status of males compared with females. Links among agricultural work (organochlorine-based pesticides), wood products, and organic solvents have been established [2].",
keywords = "Bone marrow biopsy, Chemotherapy, Combination chemotherapy, Lymph node biopsy, Monoclonal antibody therapy",
author = "Faber, {Edward A.} and Vose, {Julie Marie} and Armitage, {James Olen} and Bierman, {Philip Jay}",
year = "2013",
month = "11",
day = "1",
doi = "10.1007/978-1-4614-3764-2_47",
language = "English (US)",
isbn = "1461437636",
pages = "1027--1047",
booktitle = "Neoplastic Diseases of the Blood",
publisher = "Springer New York",

}

TY - CHAP

T1 - Diagnosis and treatment of non-Hodgkin's lymphoma of adults

AU - Faber, Edward A.

AU - Vose, Julie Marie

AU - Armitage, James Olen

AU - Bierman, Philip Jay

PY - 2013/11/1

Y1 - 2013/11/1

N2 - The non-Hodgkin's lymphomas (NHL) represent a diverse group of neoplasms with many different clinical presentations, associated laboratory abnormalities, responsiveness to treatment, and clinical outcome. The cell of origin and stage of maturation arrest prior to uncontrolled proliferation are important to the understanding of this diversity (Table 47.1). In the USA, the incidence of NHL steadily increases from childhood through age 80 years; unlike Hodgkin's disease, no peak incidence exists for young adults. NHL is the fifth most common malignancy in men and women, respectively, and is among the most rapidly increasing malignancies [1]. They represent the seventh most common cause of death from cancer in the USA, with the age-adjusted incidence being about three times that of Hodgkin's disease [1]. The incidence of non-Hodgkin's lymphoma is twice as frequent among whites as blacks, and there is an almost 50 % increase in presentation in males compared with females. The reason for this gender and race predominance is unknown; however, it may reflect a different pattern of occupational exposure or a difference in the immune status of males compared with females. Links among agricultural work (organochlorine-based pesticides), wood products, and organic solvents have been established [2].

AB - The non-Hodgkin's lymphomas (NHL) represent a diverse group of neoplasms with many different clinical presentations, associated laboratory abnormalities, responsiveness to treatment, and clinical outcome. The cell of origin and stage of maturation arrest prior to uncontrolled proliferation are important to the understanding of this diversity (Table 47.1). In the USA, the incidence of NHL steadily increases from childhood through age 80 years; unlike Hodgkin's disease, no peak incidence exists for young adults. NHL is the fifth most common malignancy in men and women, respectively, and is among the most rapidly increasing malignancies [1]. They represent the seventh most common cause of death from cancer in the USA, with the age-adjusted incidence being about three times that of Hodgkin's disease [1]. The incidence of non-Hodgkin's lymphoma is twice as frequent among whites as blacks, and there is an almost 50 % increase in presentation in males compared with females. The reason for this gender and race predominance is unknown; however, it may reflect a different pattern of occupational exposure or a difference in the immune status of males compared with females. Links among agricultural work (organochlorine-based pesticides), wood products, and organic solvents have been established [2].

KW - Bone marrow biopsy

KW - Chemotherapy

KW - Combination chemotherapy

KW - Lymph node biopsy

KW - Monoclonal antibody therapy

UR - http://www.scopus.com/inward/record.url?scp=84929542587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929542587&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-3764-2_47

DO - 10.1007/978-1-4614-3764-2_47

M3 - Chapter

AN - SCOPUS:84929542587

SN - 1461437636

SN - 9781461437635

SP - 1027

EP - 1047

BT - Neoplastic Diseases of the Blood

PB - Springer New York

ER -